Join
Live feed
·
INSIDERFilingvia Quantisnow
Replimune Group Inc. logo

Chief Medical Officer Xynos Konstantinos was granted 60,000 shares, increasing direct ownership by 43% to 199,685 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
REPL· Replimune Group Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REPL (Replimune Group Inc.) and more on Quantisnow.